April 12, 2021 Comments Off on New patent expiration for Glaxosmithkline Llc drug REQUIP XL Posted in: Uncategorized
Annual Drug Patent Expirations for REQUIP+XL Requip Xl is a drug marketed by Glaxosmithkline Llc and is included in one NDA. There are two patents protecting this drug and seven…
The post New patent expiration for Glaxosmithkline Llc drug REQUIP XL app…
April 12, 2021 Comments Off on New patent expiration for Vicuron drug ERAXIS Posted in: Uncategorized
Annual Drug Patent Expirations for ERAXIS Eraxis is a drug marketed by Vicuron and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent expiration for Vicuron drug ERAXIS appeared first on D…
